Category: St. Jude MedicalSyndicate content

FDA approves St. Jude Medical's TactiCath Quartz force-sensing catheter

October 27, 2014 by Brad Perriello

The FDA approves St. Jude Medical's TactiCath Quartz force-sensing ablation catheter for treating atrial fibrillation.

FDA approves St. Jude Medical's TactiCath Quartz force-sensing catheter

U.S. government probes medical devices for possible cyber flaws

October 22, 2014 by MassDevice

The U.S. Homeland Security Dept. is investigating reports of cybersecurity flaws in medical devices including some made by Medtronic, St. Jude Medical and Hospira.

YYmeta

(Reuters) - The U.S. Homeland Security Dept. is investigating about 2 dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical CEO: CardioMEMS the 'single most important new growth driver'

October 16, 2014 by Brian Johnson

St. Jude Medical CEO Dan Starks is bullish on the potential for recent acquisition CardioMEMS to tap the $1 billion market for treating heart failure.

St. Jude Medical CEO: CardioMEMS the 'single most important new growth driver' in portfolio

St. Jude Medical's adjusted profit rises

October 15, 2014 by MassDevice

St. Jude Medical's adjusted profits rise during the 3rd quarter as the company narrows its earnings guidance and lowers its sales outlook.

St. Jude Medical's adjusted profit rises

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

October 2, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific could take CRM lead; Orthofix CFO bails after 6 months amid deepening financial fix; Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien; Echo Therapeutics is on the ropes; Activist investor erupts at Volcano

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014

September 29, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark

Boston Scientific loses $309 million judgment in Mirowski patent war

September 24, 2014 by Brad Perriello

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alex Soule

Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.

Analyst: Boston Scientific could take pacer lead
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp